Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer

BACKGROUND: Breast cancer stem cells (BCSCs) have been suggested to have clinical implications for cancer therapeutics because of their proposed role in chemoresistance. The aim of this study was to investigate the impact of BCSC marker expression on clinical outcome and trastuzumab response in huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, An Na, Lee, Hee Jin, Kim, Eun Joo, Jang, Min Hye, Kim, Yu Jung, Kim, Jee Hyun, Kim, Sung-Won, Ryu, Han Suk, Park, In Ae, Im, Seock-Ah, Gong, Gyungyub, Jung, Kyung Hae, Kim, Hee Jeong, Park, So Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865964/
https://www.ncbi.nlm.nih.gov/pubmed/27115469
http://dx.doi.org/10.1038/bjc.2016.101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865964/
https://www.ncbi.nlm.nih.gov/pubmed/27115469
http://dx.doi.org/10.1038/bjc.2016.101

Ejemplares similares